Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex proteins. Optimizing these processes involves modifying various parameters, including cell line development, media formulation, and bioreactor conditions. A key goal is to amplify antibody yield while minimizing production finan